215 related articles for article (PubMed ID: 31922969)
1. Editorial: Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer.
Daneshmand S
Curr Opin Urol; 2020 Mar; 30(2):234. PubMed ID: 31922969
[No Abstract] [Full Text] [Related]
2. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
3. Testicular germ cell tumors: biology and clinical update.
Mannuel HD; Mitikiri N; Khan M; Hussain A
Curr Opin Oncol; 2012 May; 24(3):266-71. PubMed ID: 22343384
[TBL] [Abstract][Full Text] [Related]
4. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
5. Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors.
Heidenreich A; Paffenholz P; Nestler T; Pfister D; Daneshmand S
Curr Opin Urol; 2020 Mar; 30(2):251-257. PubMed ID: 31972635
[TBL] [Abstract][Full Text] [Related]
6. The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.
Feldman DR
Oncology (Williston Park); 2010 Jul; 24(8):761-3. PubMed ID: 20718258
[No Abstract] [Full Text] [Related]
7. Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
Matulewicz RS; Benfante N; Funt SA; Feldman DR; Carver B; Doudt A; Knezevic A; Sheinfeld J
J Urol; 2024 Jan; 211(1):80-89. PubMed ID: 37672753
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C
J Urol; 2020 Jul; 204(1):96-103. PubMed ID: 32003612
[TBL] [Abstract][Full Text] [Related]
9. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
10. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
[TBL] [Abstract][Full Text] [Related]
11. Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy.
Liu J; Thomas B; Lawrentschuk N
Eur Urol; 2023 Oct; 84(4):438-439. PubMed ID: 37385842
[No Abstract] [Full Text] [Related]
12. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
Mano R; Di Natale R; Sheinfeld J
Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
[TBL] [Abstract][Full Text] [Related]
13. [Comment to: "Primary laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ-cell testis tumor"].
Alcaraz A
Actas Urol Esp; 2011 Jan; 35(1):29-30. PubMed ID: 21322830
[No Abstract] [Full Text] [Related]
14. Clinical Stage IIA-IIC Seminoma: Radiation Therapy versus Systemic Chemotherapy versus Retroperitoneal Lymph Node Dissection.
von Amsberg G; Hamilton R; Papachristofilou A
Oncol Res Treat; 2018; 41(6):360-363. PubMed ID: 29763926
[TBL] [Abstract][Full Text] [Related]
15. Conditional risk of relapse in patients with germ cell testicular tumors: personalizing surveillance in clinical stage 1 disease.
Goldberg H; Madhur N; Hamilton RJ
Curr Opin Urol; 2018 Sep; 28(5):454-460. PubMed ID: 29916845
[TBL] [Abstract][Full Text] [Related]
16. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
17. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
18. Is there still a place for lymphadenectomy in clinical stage I non-seminoma?
Weissbach L; Boedefeld EA; Bussar-Maatz R; Kleinschmidt K
Prog Clin Biol Res; 1988; 269():407-17. PubMed ID: 2839848
[No Abstract] [Full Text] [Related]
19. Management of Stage II Germ Cell Tumors.
Ghandour RA; Singla N; Bagrodia A
Urol Clin North Am; 2019 Aug; 46(3):363-376. PubMed ID: 31277731
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic retroperitoneal lymph node dissection for stage I nonseminomatous germ cell testis tumors: the first case series in Iran.
Ziaee SA; Tabibi A; Sharifiaghdas F; Ghahestani SM; Zare S; Samzadeh M
Urol J; 2011; 8(1):27-30. PubMed ID: 21404199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]